Quarterly ResultMay 14, 2026, 04:16 PM
GeoVax Labs Q1 Net Loss $5.26M; Cash $1.27M; Going Concern Doubt
AI Summary
GeoVax Labs, Inc. reported a net loss of $(5.26) million for the first quarter of 2026, with cash and cash equivalents falling to $1.27 million. The company's existing cash resources are projected to last only until June 2026, raising substantial doubt about its ability to continue as a going concern. Revenue from government contracts ceased in Q1 2026, while the company continued to raise capital through stock and warrant offerings, providing $1.72 million in financing activities.
Key Highlights
- Substantial doubt raised about GeoVax Labs' ability to continue as a going concern.
- Q1 2026 net loss was $(5.26) million, a slight improvement from $(5.36) million in Q1 2025.
- Cash and cash equivalents decreased to $1.27 million as of March 31, 2026.
- Working capital significantly dropped to $139,783 from $3.38 million at December 31, 2025.
- Revenue from government contracts was $0 in Q1 2026, down from $1.64 million in Q1 2025.
- Net cash provided by financing activities was $1.72 million in Q1 2026.
- Research and development expenses decreased 27% to $3.90 million in Q1 2026.
- A 1-for-25 reverse stock split was effected on January 9, 2026.